X0306 4 2015-12-01 0 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001659747 Louis Roger C/O AEGERION PHARMACEUTICALS, INC. ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142 0 1 0 0 See Remarks Stock Option (right to buy) 10.42 2015-12-01 4 A 0 85000 0.00 A 2025-12-01 Common Stock 85000 85000 D The stock option award has an exercise price equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. 25% of the shares of common stock underlying this stock option award will vest on December 1, 2016. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through December 1, 2019, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer. Global Chief Compliance Officer /s/ Benjamin Harshbarger, attorney-in-fact 2015-12-02